Breast Cancer ER PR HER-2 Ki-67 Test sale cost 3600 AED
Chronic Lymphocytic Leukemia CLL Prognostic Panel Test sale cost 4210 AED Chronic Lymphocytic Leukemia CLL Prognostic Panel Test Cost 4,680 د.إ Original price was: 4,680 د.إ.4,210 د.إCurrent price is: 4,210 د.إ.
Cancer Targeted Gene Panel Colon Colorectal Test sale cost 2970 AED Cancer Targeted Gene Panel Colon Colorectal Test Cost 3,960 د.إ Original price was: 3,960 د.إ.2,970 د.إCurrent price is: 2,970 د.إ.
Sale!

Breast Cancer ER PR HER-2 Ki-67 Test Cost

Original price was: 4,000 د.إ.Current price is: 3,600 د.إ.

-10%

The “Breast Cancer ER PR HER-2 Ki-67 Test” is a comprehensive diagnostic panel used in the evaluation and management of breast cancer. This test is conducted to assess the expression of four key biomarkers: Estrogen Receptor (ER), Progesterone Receptor (PR), Human Epidermal Growth Factor Receptor 2 (HER-2), and Ki-67. These biomarkers are crucial in determining the subtype of breast cancer, which in turn influences treatment decisions and prognosis.

1. **Estrogen Receptor (ER)** and **Progesterone Receptor (PR)** testing: These tests measure the presence of hormone receptors on cancer cells. Cancers that are hormone receptor-positive are more likely to respond to hormone therapy.

2. **HER-2**: This test evaluates the overexpression of the HER-2 protein on the surface of cancer cells, which is associated with a more aggressive form of breast cancer. HER-2 positive cancers may benefit from targeted therapies.

3. **Ki-67**: This marker is used to determine the proliferation rate of cancer cells, providing insight into how quickly the cancer is likely to grow and spread. A higher Ki-67 level indicates a more aggressive cancer.

The test is priced at 3600 AED and is available at DNA Labs UAE, a leading laboratory that specializes in genetic and molecular diagnostics. DNA Labs UAE provides advanced testing services with accurate and reliable results, employing state-of-the-art technology and adhering to international standards. This test is a critical tool in the personalized treatment planning for breast cancer patients, enabling healthcare providers to tailor therapies that are most likely to be effective for each individual’s cancer subtype.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

BREAST CANCER ER PR HER-2 Ki-67 Test

Components:

  • ER
  • PR
  • HER-2
  • Ki-67
  • Includes Pathologist review for presence of malignant cells

Price: 3600.0 AED

Sample Condition:

Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Clinical history & indicate site of biopsy.

Report Delivery: 10 days

Method: Immunohistochemistry

Test type: Cancer

Doctor: Oncologist

Test Department: HISTOLOGY

Pre Test Information:

Provide a copy of the Histopathology report, Clinical history & indicate site of biopsy.

Test Details:

Breast cancer ER (estrogen receptor), PR (progesterone receptor), HER-2 (human epidermal growth factor receptor 2), and Ki-67 are all biomarkers used to determine the characteristics of breast cancer cells. ER and PR are hormone receptors that help determine if the cancer cells are sensitive to estrogen and progesterone. A positive ER or PR status means that the cancer cells are sensitive to these hormones and can be treated with hormone therapy. HER-2 is a protein that is overexpressed in some breast cancer cells. HER-2 positive breast cancer is typically more aggressive and may require targeted therapies such as Herceptin. Ki-67 is a protein that indicates the level of cell proliferation or how fast the cancer cells are dividing. A higher Ki-67 index suggests a more aggressive tumor. These biomarkers are important in determining the treatment options for breast cancer. They help guide decisions regarding hormone therapy, targeted therapies, and chemotherapy.

Test Name BREAST CANCER ER PR HER-2 Ki-67 Test
Components *ER*PR*HER-2*Ki-67*Includes Pathologist review for presence of malignant cells
Price 3600.0 AED
Sample Condition Submit tumor tissue in 10% Formal-saline \nOR Formalin fixedparaffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Clinical history & indicate site of biopsy.
Report Delivery 10 days
Method Immunohistochemistry
Test type Cancer
Doctor Oncologist
Test Department: HISTOLOGY
Pre Test Information Provide a copy of the Histopathology report, Clinical history & indicate site of biopsy.
Test Details

Breast cancer ER (estrogen receptor), PR (progesterone receptor), HER-2 (human epidermal growth factor receptor 2), and Ki-67 are all biomarkers used to determine the characteristics of breast cancer cells.

ER and PR are hormone receptors that help determine if the cancer cells are sensitive to estrogen and progesterone. A positive ER or PR status means that the cancer cells are sensitive to these hormones and can be treated with hormone therapy.

HER-2 is a protein that is overexpressed in some breast cancer cells. HER-2 positive breast cancer is typically more aggressive and may require targeted therapies such as Herceptin.

Ki-67 is a protein that indicates the level of cell proliferation or how fast the cancer cells are dividing. A higher Ki-67 index suggests a more aggressive tumor.

These biomarkers are important in determining the treatment options for breast cancer. They help guide decisions regarding hormone therapy, targeted therapies, and chemotherapy.

SKU: TEST-4690 Category:

Related products